Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Paquissi, Feliciano Chanana
2017.
Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis.
Frontiers in Immunology,
Vol. 8,
Issue. ,
Li, Fenghua
Yang, Yang
Yang, Lili
Wang, Kai
Zhang, Xing
Zong, Yunlong
Ding, Yixin
Wang, Changhong
Zhang, Li
and
Ji, Guang
2017.
Resveratrol alleviates FFA and CCl4 induced apoptosis in HepG2 cells via restoring endoplasmic reticulum stress.
Oncotarget,
Vol. 8,
Issue. 27,
p.
43799.
Roh, Yoon-Seok
and
Seki, Ekihiro
2018.
Obesity, Fatty Liver and Liver Cancer.
Vol. 1061,
Issue. ,
p.
45.
Cha, Ji-Young
Kim, Da-Hyun
and
Chun, Kyung-Hee
2018.
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Laboratory Animal Research,
Vol. 34,
Issue. 4,
p.
133.
Chen, Wei
Zhang, Jing
Fan, Hui-Ning
and
Zhu, Jin-Shui
2018.
Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease.
Therapeutic Advances in Gastroenterology,
Vol. 11,
Issue. ,
Kanda, Tatsuo
Matsuoka, Shunichi
Yamazaki, Motomi
Shibata, Toshikatsu
Nirei, Kazushige
Takahashi, Hiroshi
Kaneko, Tomohiro
Fujisawa, Mariko
Higuchi, Teruhisa
Nakamura, Hitomi
Matsumoto, Naoki
Yamagami, Hiroaki
Ogawa, Masahiro
Imazu, Hiroo
Kuroda, Kazumichi
and
Moriyama, Mitsuhiko
2018.
Apoptosis and non-alcoholic fatty liver diseases.
World Journal of Gastroenterology,
Vol. 24,
Issue. 25,
p.
2661.
Middleton, Sarah A.
Rajpal, Neetu
Cutler, Leanne
Mander, Palwinder
Rioja, Inmaculada
Prinjha, Rab K.
Rajpal, Deepak
Agarwal, Pankaj
and
Kumar, Vinod
2018.
BET Inhibition Improves NASH and Liver Fibrosis.
Scientific Reports,
Vol. 8,
Issue. 1,
Ezzaidi, Niama
Zhang, Xiang
Coker, Olabisi Oluwabukola
and
Yu, Jun
2019.
New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.
Cancer Letters,
Vol. 459,
Issue. ,
p.
186.
Robinson, Stuart M.
Rasch, Sebastian
Beer, Sebastian
Valantiene, Irena
Mickevicius, Artautas
Schlaipfer, Elisabeth
Mann, Jelena
Maisonneuve, Patrick
Charnley, Richard M.
and
Rosendahl, Jonas
2019.
Systemic inflammation contributes to impairment of quality of life in chronic pancreatitis.
Scientific Reports,
Vol. 9,
Issue. 1,
Ku, Eu Jeong
Cho, Kyung-Cho
Lim, Cheong
Kang, Jeong Won
Oh, Jae Won
Choi, Yu Ri
Park, Jong-Moon
Han, Na-Young
Oh, Jong Jin
Oh, Tae Jung
Jang, Hak Chul
Lee, Hookeun
Kim, Kwang Pyo
and
Choi, Sung Hee
2020.
Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics.
BMJ Open Diabetes Research & Care,
Vol. 8,
Issue. 1,
p.
e001152.
Bhattacharya, Shoumo
and
Kawamura, Akane
2020.
Inflammatory Disorders, Part A.
Vol. 119,
Issue. ,
p.
1.
Pan, Xiongfeng
Chiwanda Kaminga, Atipatsa
Liu, Aizhong
Wen, Shi Wu
Chen, Jihua
and
Luo, Jiayou
2020.
Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
Frontiers in Immunology,
Vol. 11,
Issue. ,
Li, Jinwang
Xie, Siyu
and
Teng, Wendi
2021.
Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.
Nutrients,
Vol. 14,
Issue. 1,
p.
76.
Ma, Hong‐Lei
Chen, Sui‐Dan
Zheng, Kenneth I
Yu, Yue
Wang, Xin‐Xin
Tang, Liang‐Jie
Li, Gang
Rios, Rafael S
Huang, Ou‐Yang
Zheng, Xiao‐Yong
Xu, Ren‐Ai
Targher, Giovanni
Byrne, Christopher D
Wang, Xiao‐Dong
Chen, Yong‐Ping
and
Zheng, Ming‐Hua
2021.
TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy‐proven nonalcoholic fatty liver disease.
Journal of Gastroenterology and Hepatology,
Vol. 36,
Issue. 10,
p.
2925.
Aghbash, Parisa Shiri
Hemmat, Nima
Nahand, Javid Sadri
Shamekh, Ali
Memar, Mohammad Yousef
Babaei, Abouzar
and
Baghi, Hossein Bannazadeh
2021.
The role of Th17 cells in viral infections.
International Immunopharmacology,
Vol. 91,
Issue. ,
p.
107331.
Du, Xiaomi
DeForest, Natalie
and
Majithia, Amit R.
2021.
Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities.
Frontiers in Endocrinology,
Vol. 12,
Issue. ,
Jiang, Hui
Mao, Tangyou
Liu, Yuyue
Tan, Xiang
Sun, Zhongmei
Cheng, Yuan
Han, Xiao
Zhang, Yang
Wang, Jiali
Shi, Lei
Guo, Yi
Li, Junxiang
and
Han, Haixiao
2022.
Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification.
Frontiers in Pharmacology,
Vol. 13,
Issue. ,
Lee, Nami
Heo, Yu Jung
Choi, Sung-E
Jeon, Ja Young
Han, Seung Jin
Kim, Dae Jung
Kang, Yup
Lee, Kwan Woo
and
Kim, Hae Jin
2022.
Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease.
Biochemical and Biophysical Research Communications,
Vol. 588,
Issue. ,
p.
154.
Mao, Tianyu
Yang, Rui
Luo, Yi
and
He, Kang
2022.
Crucial role of T cells in NAFLD-related disease: A review and prospect.
Frontiers in Endocrinology,
Vol. 13,
Issue. ,
Aljabban, Jihad
Rohr, Michael
Syed, Saad
Khorfan, Kamal
Borkowski, Vincent
Aljabban, Hisham
Segal, Michael
Mukhtar, Mohamed
Mohammed, Mohammed
Panahiazar, Maryam
Hadley, Dexter
Spengler, Ryan
and
Spengler, Erin
2022.
Transcriptome changes in stages of non-alcoholic fatty liver disease.
World Journal of Hepatology,
Vol. 14,
Issue. 7,
p.
1382.